Rapid antigen diagnostic testing to confirm respiratory syncytial virus (RSV) infections in young children was linked to fewer unnecessary antibiotic prescriptions in outpatient settings, according to ...

Scientists found that RSV infection early in life can set the stage for childhood asthma, particularly in kids already genetically prone to allergies. The virus appears to skew the developing immune ...

Respiratory syncytial virus (RSV) is a common virus that can cause severe respiratory illness in infants and young children, including lower respiratory tract infections (LRTIs) such as bronchiolitis ...

As the number of respiratory syncytial virus (RSV) infections rises nationwide, attention is turning to two recent studies that found protecting babies against the disease - by vaccinating pregnant ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new dual-antibody treatment shows promise against Respiratory Syncytial Virus (RSV), a ...

Australia's new respiratory syncytial virus (RSV) immunization program cut hospital admissions for Australia's youngest babies by almost half in its first year, a new major national study has shown.

Nirsevimab is a long-acting monoclonal antibody that provides season-long protection against RSV in infants, reducing medically attended infections and hospitalizations. Maternal vaccination and ...